ASRC Press Releases

NARB Recommends Charter Drop ‘Again’ from Grim Reaper’s Complaint About DirecTV Satellite Television Service

New York, NY – July 26, 2018 –  A panel of the National Advertising Review Board has recommended that Charter Communications discontinue use of the word “again” in a commercial in which the Grim Reaper states that his family’s satellite dish “went out in the rain, again.” The panel also recommended that Charter discontinue claims that contrast satellite TV as unreliable and its Spectrum TV service as reliable. The panel determined that the challenged commercial conveyed the messages that satellite TV users will experience frequent and regular outages in the rain and that...

Read More

NARB Panel Recommends AT&T Modify Claims Regarding Availability of ‘AT&T Fiber

New York, NY – July 24, 2018 – A panel of the National Advertising Review Board has recommended that AT&T Services, Inc., modify advertising to clarify for consumers the availability of AT&T Fiber, the company’s fiber-to-the-home product, but declined to recommend that AT&T refrain from market-wide advertising in markets where AT&T Fiber is available to less than 20% of the market. NARB is the appellate unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus. AT&T’s advertising claims were...

Read More

ERSP Finds Reliefband Can Support Certain Claims for Anti-Nausea Product; Recommends Marketer Modify, Discontinue Other Claims

New York, NY – July 20, 2018 – The Electronic Retailing Self-Regulation Program (ERSP) has found that Reliefband Technologies, LLC can support certain claims for Reliefband, wearable technology designed to alleviate symptoms primarily associated with motion sickness, but recommended the marketer modify or discontinue other claims. ERSP is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus. The marketer’s advertising came to the attention of ERSP pursuant to its ongoing monitoring program. ERSP...

Read More

NAD Recommends Telebrands Discontinue Certain Claims for ‘Atomic Beam’ Flashlights; Advertiser to Appeal NAD’s BOGO Finding

New York, NY – July 19, 2018 – The National Advertising Division has recommended that Telebrands, Corp., discontinue certain advertising claims for the company’s Atomic Beam flashlights, including claims that they are “40 times brighter” and more durable than ordinary flashlights and are equipped with features that ordinary flashlights do not provide. NAD noted that nothing in its decision precludes the advertiser from making comparative claims regarding the Atomic Beam and competing flashlights provided that the claims are supported by comparative testing and clearly disclose the...

Read More

NAD Recommends Tru Derma Discontinue Claims, Testimonials for Mangodrin Supplement Following CRN Challenge

New York, NY – July 18, 2018 – The National Advertising Division has recommended that Tru Derma, LLC, discontinue advertising claims challenged by the Council for Responsible Nutrition, for the company’s Mangodrin XTREME Formula and Mangodrin Stimulant Free dietary supplements. NAD is an investigative unit of the advertising industry’s self-regulatory system. It is administered by the Council of Better Business Bureaus. Claims at issue included: “Lose Up To 28 lbs. In just 10 Weeks” “Increase Energy & Mental Focus” “See Results In 14 Days” “Control Appetite &...

Read More

NAD Recommends Chattem Discontinue ‘Twice As Fast’ Claim for Xyzal Following Challenge from Claritin Maker Bayer HealthCare

New York, NY – July 18, 2018 – The National Advertising Division has recommended that Chattem, Inc., discontinue claims that the company’s Xyzal Allergy 24 HR product works “Twice as fast as Claritin” and provides “relief that starts at hour 1 instead of hour 2.” NAD is an investigative unit of the advertising industry’s self-regulatory system. It is administered by the Council of Better Business Bureaus. The claims at issue were challenged by Bayer HealthCare LLC, maker of Claritin. Both Bayer’s Claritin and Chattem’s Xyzal are over-the-counter oral antihistamines...

Read More